MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Aberrant dopamine transporter and functional connectivity patterns in LRRK2 and GBA non-manifesting carriers

    A. Droby, M. Artzi, H. Lerman, RM. Hutchison, D. Ben Bashat, N. Omer, T. Gurevich, A. Orr-Urtreger, B. Cohen, J. Cedarbaum, E. Even Sapir, N. Giladi, A. Mirelman, A. Thaler (Tel Aviv, Israel)

    Objective: We aimed to study the association between presynaptic striatal dopamine uptake and functional connectivity (FC) patterns among healthy first-degree relatives of PD patients with…
  • MDS Virtual Congress 2021

    Parkinson Disease with, but not without, Cognitive Decline Reveals Advanced Brain Aging

    MC. Kuo, CL. Chen, RM. Wu, WY. Tseng (Taipei, Taiwan)

    Objective: To investigate “brain age” in Parkinson disease (PD) with and without cognitive decline, and its correlation with motor and cognitive performance. Background: Although brain…
  • MDS Virtual Congress 2021

    Baseline and six months change in cortical perfusion in a mesenchymal stem cell trial for Parkinson’s disease

    M. Schiess, J. Suescun, S. Chandra, V. Thyne, T. Ellmore (Houston, USA)

    Objective: Quantify cortical perfusion at baseline and six months after a single infusion of allogeneic bone marrow-derived mesenchymal stem cells (allo-hMSC) in relation to demographic…
  • MDS Virtual Congress 2021

    Neurofilament light is related to fractional anisotropy in early Parkinson’s diesease

    T. Welton, Y. Tan, S. Saffari, N. Chia, S. Ng, Z. Lu, A. Yong, X. Choi, D. Heng, YC. Shih, S. Hartono, W. Lee, Z. Xu, K. Tay, WL. Au, EK. Tan, LL. Chan, A. Ng, L. Tan (Singapore, Singapore)

    Objective: We aimed to determine whether plasma NfL reflects changes in brain white matter integrity as measured using fractional anisotropy (FA) in patients with early…
  • MDS Virtual Congress 2021

    Long-term effect of safinamide on primary motor cortex excitability and plasticity in Parkinson’s disease: a TMS study

    V. D'Onofrio, A. Guerra, F. Asci, G. Fabbrini, A. Berardelli, A. Suppa (Rome, Italy)

    Objective: To examine the long-term effect of chronic treatment with safinamide 100 mg/day on specific Transcranial Magnetic Stimulation (TMS) measures of primary motor cortex (M1)…
  • MDS Virtual Congress 2021

    ON/OFF Blood Pressure Fluctuation in Parkinson’s Disease

    K. Chung, B. Lobb (Portland, USA)

    Objective: To examine ON and OFF blood pressure (BP) fluctuations in Parkinson’s Disease (PD) patients. Background: The current practice often is to treat transient hypertensive…
  • MDS Virtual Congress 2021

    Idiopathic Parkinson’s disease and Sensory disorders: A complication of dopatherpy or an intrinsic feature of the disease?

    S. Laroussi, N. Farhat, S. Sakka, R. Boukhdhir, H. Zouari, M. Damak, C. Mhiri (Sfax, Tunisia)

    Objective: Evaluate the occurrence of sensory disorders (SD) in Idiopathic Parkinson’s disease (IPD) and the impact of treatment in developing peripheral neuropathy (PN). Background: SD…
  • MDS Virtual Congress 2021

    Vitamin D and Parkinson’s disease

    D. Novotnyy (Novosibirsk, Russian Federation)

    Objective: to study the correlation between vitamin D levels (deficiency) and clinical presentations in patients with Parkinson’s disease Background: previous studies throughout the world have…
  • MDS Virtual Congress 2021

    Relationship between frequency and severity of REM sleep behavior disorder and clinical features in patients with Parkinson’s disease

    JY. Wang, Y. Shen, CF. Liu (Suzhou, China)

    Objective: We aimed to explore the relationship between  frequency and severity of REM sleep behavior disorder(RBD) and clinical characteristics in Parkinson's disease (PD) patients. Background:…
  • MDS Virtual Congress 2021

    Comparative score on the MDS-UPDRS scale I, II and IV in patients with Parkinson disease with and without cardiovascular risk factors.

    H. Gonzalez-Usigli, A. Gonzalez-Vazquez, J. Garcia-Rivera, O. Padila-Delatorre, A. Leon-Gil, H. Gonzalez-Rodriguez (Guadalajara, Mexico)

    Objective: To find any relationship between cardiovascular risk factors such as diabetes mellitus, hypertension or both and worse state in patient with PD measured with…
  • « Previous Page
  • 1
  • …
  • 276
  • 277
  • 278
  • 279
  • 280
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • Nilotinib for treating MSA: A preclinical proof of concept study
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley